Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Neosil logo — A dermatology-focused pharmaceutical pioneer with innovative...

Neosil

A dermatology-focused pharmaceutical pioneer with innovative hair growth solutions and advanced topical anti-microbial agents for acne and infections.

Founded 2004 Debt Financing Total: $42.00M Biotechnology

General Information

Company Name Neosil
Founded Year 2004
Industries Biotechnology
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Neosil. To contact Neosil, visit neosil.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Neosil

Neosil, Inc. is a biotechnology startup founded in 2004 that has garnered attention for its groundbreaking work in dermatology pharmaceuticals. With a focus on innovative hair growth solutions and advanced topical anti-microbial agents for acne and infections, the company has distinguished itself as a pioneer in the field. Its topical hair growth product, developed and ready for market, has established Neosil as a formidable player in dermatology. Additionally, the company is in the process of developing a broad-spectrum topical anti-microbial agent, further solidifying its position as a leader in the industry. Notable in Neosil's trajectory is its $10.00M debt financing investment in 02 May 2007, with Hercules Capital coming on as the investor. This influx of funding has undoubtedly supported the company's research and development efforts, as well as its operational and marketing activities. Neosil's continued growth presents an intriguing opportunity for venture capital firms seeking to invest in biotechnology startups with a focus on dermatology. As the company remains on the cutting edge of pharmaceutical innovation, its potential for sizable returns on investment is worth serious consideration for venture capitalists looking to capitalize on emerging trends in the biotechnology sector.

Taxonomy: dermatology, pharmaceutical, hair growth, topical, anti-microbial, acne, infections, topical products, dermatology pharmaceutical, broad-spectrum agents, anti-infective, medical innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $10.00M 1
Hercules Capital
Hercules Capital
02 May 2007
Series A $32.00M 3
MPM Capital Burrill & Company Shalon Ventures
MPM Capital, Burrill & Company +1
08 Nov 2004

Neosil Alternatives & Competitors

Neosil vs
Sebacia
Sebacia United States

Sebacia Microparticles is a novel FDA-cleared acne treatment, representing the newest innovation in...

Venture round
1 employees
Biotechnology, Medical Devices
Neosil vs
Topica Pharmaceuticals
Topica Pharmaceuticals

Developing the first highly effective and safe topical therapy for onychomycosis.

Venture round
Biotechnology, Medical Devices
Neosil vs
Microbion Corporation
Microbion Corporation United States

Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic, and serio...

Venture round
16 employees
Biotechnology, Health Care

FAQ About Neosil

A dermatology-focused pharmaceutical pioneer with innovative hair growth solutions and advanced topical anti-microbial agents for acne and infections.
Neosil was founded in 2004.
Neosil operates in Biotechnology. Its work centres on dermatology, pharmaceutical, hair growth and topical.
Neosil has completed 2 funding rounds, raising a total of $42.00M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Neosil include Sebacia, Topica Pharmaceuticals, Microbion Corporation, Ai2 Ltd, Hallux Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neosil and Sebacia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neosil, https://bouncewatch.com/company/neosil, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes